A patent provides its owner with an exclusive right to a new invention. And beginning in the 1990s, the U.S. Patent and Trademark Office granted a multitude to OMRF, sometimes more than a dozen in a single year. Only a decade earlier did Congress give OMRF and others the right to patent inventions that stemmed […]
A Time of Growth
When Dr. William Thurman, above, took the helm of OMRF, he brought the lab coat he’d worn since his days training as a pediatric oncologist. That powder-blue garment, along with the bow ties he favored, would become synonymous with OMRF throughout the 1980s (and most of the 1990s). But his sartorial flourishes would prove the […]
OMRF enters into a license agreement with Shanghai RAAS Blood Products
OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.
OMRF collaborates with GSK to develop novel treatments for severe inflammatory diseases
This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.
Venture capital, biotech execs converge on OMRF
Networking, lab tours highlight first OMRF BioVenture Forum
OMRF researcher receives American Heart Association award
OMRF’s Charles Esmon was recognized by the AHA as a distinguished scientist.